SCHEMBL11027795

SCHEMBL11027795

Nc1nc2ccccn2c1-c1cccnn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP7 Q93009 3/20 0.52
CDK4 P11802 3/20 0.45
CDK2 P24941 3/20 0.45
ALDH1A1 P00352 4/20 0.41
KDM4E B2RXH2 3/20 0.41
GAA P10253 3/20 0.41
HPGD P15428 2/20 0.41
HSD17B10 Q99714 2/20 0.41
GLA P06280 2/20 0.41
NPC1 O15118 1/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
DAPK3 O43293 1/20 0.40
JAK2 O60674 1/20 0.40
PRKD3 O94806 1/20 0.40
MAP4K4 O95819 1/20 0.40
ABL1 P00519 1/20 0.40
CSF1R P07333 1/20 0.40
RET P07949 1/20 0.40
MET P08581 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11026169 0.77 PIK3CA (0.37) USP7DYRK1APIK3CAMTOR
SCHEMBL19048703 0.74 USP7 (0.76) USP7CDK4CDK2ALDH1A1KDM4E
SCHEMBL11028623 0.73 USP7 (0.69) USP7CDK4CDK2ALDH1A1KDM4E
SCHEMBL752298 0.73 USP7 (0.52) USP7CDK4CDK2ALDH1A1KDM4E
SCHEMBL11026812 0.73 USP7 (0.60) USP7CDK4CDK2ALDH1A1KDM4E
SCHEMBL11031736 0.69 USP7 (0.63) USP7CDK4CDK2ALDH1A1KDM4E
SCHEMBL24242364 0.66 KDM4E (0.52) USP7CDK4CDK2ALDH1A1KDM4E
SCHEMBL19700040 0.66 KDM4E (0.52) USP7CDK4CDK2ALDH1A1KDM4E
SCHEMBL9923883 0.66 ALDH1A1 (0.53) USP7CDK4CDK2ALDH1A1KDM4E
SCHEMBL8860107 0.64 ALDH1A1 (0.59) CDK4CDK2ALDH1A1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120190666-A1 Heteroaryl Compounds as PIKK Inhibitors AMGEN INC. (US) 2012-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120190666-A1 Heteroaryl Compounds as PIKK Inhibitors PIK3CA, PIKFYVE, PIK3CD USP7 3522/4885CDK4 207/4885CDK2 189/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.